stockrowMettler-Toledo International, Inc.
MTD Healthcare Diagnostics & Research
Mettler-Toledo International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 3.98% from fiscal 2024.
- Revenue
- +6.27%
- EPS
- +16.2%
- Free cash flow
- +33.0%
- Total debt
- −8.42%
Quarter to September 2026, against a year earlier
Follow MTD
Alert me
Mettler-Toledo International, Inc. (MTD) Return on equity
Mettler-Toledo International, Inc.'s return on equity over the twelve months to 30 September 2026 was −1,089.1%, up 65.8 percentage points from fiscal 2025 (−1,154.9%). Over the past ten years it has ranged from −1,260.6% (fiscal 2023) to 889.3% (fiscal 2022); the current reading is higher than 18% of that period. That is below the Diagnostics & Research industry median of 0.00% and below the Healthcare sector median of −26.3%.
Return on equity, annual
Embed this chart
Annual newest first
| Period | Return on equity | Change (points) |
|---|---|---|
| FY2025 | −1,154.9% | (531.28) |
| FY2024 | −623.6% | 637.00 |
| FY2023 | −1,260.6% | (2,149.93) |
| FY2022 | 889.3% | 550.65 |
| FY2021 | 338.7% | 167.32 |
| FY2020 | 171.4% | 60.35 |
| FY2019 | 111.0% | 20.88 |
| FY2018 | 90.1% | 13.58 |
| FY2017 | 76.6% | 0.85 |
| FY2016 | 75.7% | 21.43 |
Against its own ten years
Return on equity against peers
| Company | Return on equity |
|---|---|
| GH Guardant Health, Inc. compare | 153.9% |
| IDXX IDEXX Laboratories, Inc. compare | 68.9% |
| ILMN Illumina, Inc. compare | 32.4% |
| IQV IQVIA Holdings Inc. compare | 21.3% |
| A Agilent Technologies, Inc. compare | 21.0% |
| DGX Quest Diagnostics Incorporated compare | 14.8% |
| LH Labcorp Holdings Inc. compare | 11.5% |
| WAT Waters Corporation compare | 0.00% |
| MTD Mettler-Toledo International, Inc. | −736.4% |
| Diagnostics & Research industry median | 0.00% |
| Healthcare sector median | −26.3% |
| Market median | 0.51% |
What Return on equity is
ROE shows how much profit a company earns for its shareholders on the equity they have in the business.
Annual: Net Income Allotted to Shareholders ÷ Average Common Equity; TTM: Net Income Allotted to Shareholders ÷ Average Common Equity (latest quarter)
More on MTD
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement